found that GSTP1 promoter was methylated in 44.6% of cases, but the methylation decreased with cancer progression, it classified Ta versus T1 stages and distinguished LG versus HG tumors (Sacristan et al., 2014). The gene discussed is GSTP1; the disease is cancer.